Search results for "time factor"

showing 10 items of 3219 documents

Early detection of pneumonia in febrile neutropenic patients: use of thin-section CT.

1997

The purpose of this study was to evaluate the usefulness of thin-section CT for early detection of pneumonia in neutropenic patients with an unknown site of infection and normal or nonspecific findings on chest radiographs.Eighty-seven patients with febrile neutropenia that persisted for more than 2 days despite empiric antibiotic treatment underwent 146 prospective examinations. If findings on chest radiographs were normal (n = 126) or nonspecific (n = 20), thin-section CT (1-mm collimation, 10-mm increment) was done. If thin-section CT scans showed opacities, bronchoalveolar lavage was recommended.Findings on chest radiographs were nonspecific for pneumonia in 20 (14%) of 146 cases, and C…

Malemedicine.medical_specialtyNeutropeniaTime FactorsRadiographyAntineoplastic AgentsNeutropeniaFever of Unknown OriginPredictive Value of TestsRisk FactorsNeoplasmsmedicineHumansRadiology Nuclear Medicine and imagingProspective StudiesMycosisLeukopeniamedicine.diagnostic_testbusiness.industryRespiratory diseasePneumoniaGeneral MedicineMiddle Agedmedicine.diseaserespiratory tract diseasesSurgeryPneumoniaBronchoalveolar lavageEvaluation Studies as TopicFemaleRadiologymedicine.symptomTomography X-Ray ComputedbusinessBronchoalveolar Lavage FluidFebrile neutropeniaAmerican Journal of Roentgenology
researchProduct

Real-time ultrasonography in the otolaryngology office setting

1993

Over the past two decades, diagnostic ultrasonography has evolved into an extensively used noninvasive imaging modality. It plays a vital role in the disciplines of vascular surgery, cardiology, neonatology, pediatrics, ophthalmology, gynecology, and urology, to name a few, but it is in the field of obstetrics that this technology has been maximally used as an office procedure to evaluate the status of the fetus. In the evaluation of head and neck disorders, ultrasonography has been the subject of sporadic reports for the past 15 years.le3 However, except for the evaluation of thyroid masses,4 it has never been widely accepted in the United States as a diagnostic modality, and has taken a b…

Malemedicine.medical_specialtyNoninvasive imagingTime FactorsModality (human–computer interaction)medicine.diagnostic_testbusiness.industryMEDLINEMagnetic resonance imagingVascular surgeryPhysicians' OfficesSurgeryOtolaryngologyOtorhinolaryngologyOtorhinolaryngologyNeoplasmsmedicineHumansFemaleMedical physicsReal time ultrasonographyHead and neckbusinessUltrasonographyAmerican Journal of Otolaryngology
researchProduct

Paroxysmal atrial fibrillation and high degree AV block: use of single-lead VDDR pacing with mode switching.

1998

Dual chamber rate responsive pacing incorporating a mode switching option is increasingly used in patients with chronic paroxysmal atrial fibrillation and high degree AV block. Single-lead VDDR pacemakers have rarely used for this indication. The purpose of this study was to determine their reliability of atrial sensing during atrial fibrillation, the percentage of atrial synchronous ventricular pacing, and the behavior of the sinus rate outside the phases of atrial fibrillation. We studied ten patients with a single-lead VDDR pacemaker implanted for this indication. Follow-up visits were performed at predischarge and after 1, 3, 6, 12, 18, and 24 months. During the mean follow-up period of…

Malemedicine.medical_specialtyPacemaker ArtificialTime FactorsParoxysmal atrial fibrillationVentricular stimulationInternal medicineAtrial FibrillationMedicineHumansSinus rhythmIn patientcardiovascular diseasesbusiness.industryP waveCardiac Pacing ArtificialAtrial fibrillationGeneral MedicineMiddle Agedmedicine.diseaseHeart BlockSingle leadAnesthesiacardiovascular systemCardiologyMode switchingFemaleCardiology and Cardiovascular MedicinebusinessFollow-Up StudiesPacing and clinical electrophysiology : PACE
researchProduct

Pacemaker-Based Cardiac Neuromodulation Therapy in Patients With Hypertension: A Pilot Study.

2021

Background In prior unblinded studies, cardiac neuromodulation therapy (CNT) employing a sequence of variably timed short and longer atrioventricular intervals yielded sustained reductions of systolic blood pressure (SBP) in patients with hypertension. The effects of CNT on SBP were investigated in this double‐blind randomized pilot study. Methods and Results Eligible patients had daytime ambulatory SBP (aSBP) ≥130 mm Hg and office SBP ≥140 mm Hg despite taking ≥1 antihypertensive medication, and an indication for a dual‐chamber pacemaker. Patients underwent Moderato device implantation, which was programmed as a standard pacemaker during a 1‐month run‐in phase. Patients whose daytime aSBP…

Malemedicine.medical_specialtyPacemaker ArtificialTime Factorshypertensionatrioventricular interval ; hypertension ; left ventricular function ; pacemakerBlood PressurePilot ProjectsArrhythmiasVentricular Function LeftDouble-Blind MethodHeart RateInternal medicineMedicineHumansIn patientProspective StudiesSequence (medicine)AgedOriginal ResearchAged 80 and overbusiness.industryCardiac Pacing ArtificialEditorialsHeartNeuromodulation (medicine)EuropeTreatment OutcomeEditorialCardiologyFemaleCardiology and Cardiovascular Medicinebusinesshigh blood pressureJournal of the American Heart Association
researchProduct

How to treat tumefactive demyelinating disease?

2013

Glioma-like inflammatory demyelinating lesions can be found in patients with pre-diagnosed multiple sclerosis, but they have also been described as an isolated disease entity. The initial diagnostic work-up usually includes a biopsy for histopathological analysis. However, even after unambiguous histopathologic classification, tumefactive lesions pose a therapeutic challenge. Until now, there have been no guidelines on how to treat patients with these rare and extreme lesion phenotypes. Here we report a patient with a relapsing unifocal tumefactive demyelinating lesion. The patient initially showed a good response to steroid treatment, with full clinical recovery. However, after relapse of…

Malemedicine.medical_specialtyPathologyTime FactorsBiopsymedicine.medical_treatmentDrug Administration ScheduleLesionRecurrenceInduction therapyBiopsymedicineDemyelinating diseaseHumansIn patientmedicine.diagnostic_testDrug Substitutionbusiness.industryMultiple sclerosisImmunosuppressionMiddle Agedmedicine.diseaseMagnetic Resonance ImagingRegimenTreatment OutcomeNeurologyDrug Therapy CombinationSteroidsNeurology (clinical)Radiologymedicine.symptombusinessImmunosuppressive AgentsDemyelinating DiseasesMultiple Sclerosis Journal
researchProduct

The Role of Tumor Volume in ‘Reoxygenation’ upon Cyclophosphamide Treatment

1995

The effect of cyclophosphamide (CP) injection (60 mg/kg i.p., single dose) on volume growth and tissue oxygenation (pO2 distribution) was investigated in rat DS-sarcomas. CP was administered 4 days after subcutaneous (s.c.) tumor implantation (volume approximately 0.35 ml). Polarographic pO2 measurements were performed in the subcutis at the hind foot dorsum and in tumors 72 h after CP administration. The oxygenation status of these tissues was compared with that of saline-treated controls. CP-injection caused a mean growth delay of 11 days in DS-sarcomas and had no impact on the oxygenation status of the subcutis. In contrast, in s.c. growing DS-sarcomas the pO2 distribution improved signi…

Malemedicine.medical_specialtyPathologyTime FactorsCyclophosphamidePartial PressureUrologyBlood PressureHematocritRats Sprague-DawleyHemoglobinsOxygen ConsumptionAnimalsMedicineDistribution (pharmacology)Radiology Nuclear Medicine and imagingCyclophosphamidemedicine.diagnostic_testbusiness.industryTumor shrinkageHematologyGeneral MedicineOxygenationCarbon Dioxidemedicine.diseaseCyclophosphamide treatmentRatsOxygenKineticsHematocritOncologyVolume (thermodynamics)FemaleSarcoma ExperimentalSarcomabusinessCell DivisionPolarographymedicine.drugActa Oncologica
researchProduct

Differences in intermittent postural control between normal-weight and obese children.

2016

Abstract Aim The main objective of this study was to determine differences in postural control between obese and non-obese children. Methods The study design was cross-sectional, prospective, between-subjects. Postural control variables were obtained from a group of obese children and a normal-weight control group under two different postural conditions: bipedal standing position with eyes open and bipedal standing with eyes closed. Variables were obtained for each balance condition using time domain and sway-density plot analysis of the center of pressure signals acquired by means of a force plate. Results Pairwise comparisons revealed significant differences between obese and normal-weigh…

Malemedicine.medical_specialtyPediatric ObesityTime FactorsAdolescentCross-sectional studyPostureBiophysics030209 endocrinology & metabolismPostural controlPassive control03 medical and health sciences0302 clinical medicinePhysical medicine and rehabilitationCenter of pressure (terrestrial locomotion)medicinePostural BalanceHumansOrthopedics and Sports MedicineProspective StudiesProspective cohort studyChildPostural Balancebusiness.industryRehabilitationBody WeightCross-Sectional StudiesNormal weightSensation DisordersPhysical therapyReflexFemalebusiness030217 neurology & neurosurgeryGaitposture
researchProduct

Estimation of lead-time bias and its impact on the outcome of surveillance for the early diagnosis of hepatocellular carcinoma.

2014

Lead-time is the time by which diagnosis is anticipated by screening/surveillance with respect to the symptomatic detection of a disease. Any screening program, including surveillance for hepatocellular carcinoma (HCC), is subject to lead-time bias. Data regarding lead-time for HCC are lacking. Aims of the present study were to calculate lead-time and to assess its impact on the benefit obtainable from the surveillance of cirrhotic patients. Background & Aims: Lead-time is the time by which diagnosis is anticipated by screening/surveillance with respect to the symptomatic detection of a disease. Any screening program, including surveillance for hepatocellular carcinoma (HCC), is subject to …

Malemedicine.medical_specialtyPediatricsCarcinoma HepatocellularTime FactorsHepatocellular carcinomaSettore MED/12 - GASTROENTEROLOGIADiseaseGastroenterologyBiasInternal medicineOverall survivalmedicineHumansEarly Detection of CancerAgedEstimationSurveillanceHepatologybusiness.industryLiver Neoplasmsmedicine.diseasedigestive system diseasesLead time biasCirrhosisHepatocellular carcinomaFemalebusinessLead-time biasFollow-Up Studies
researchProduct

Fabry disease in children and response to enzyme replacement therapy: results from the Fabry Outcome Survey

2011

The Fabry Outcome Survey (FOS) was established to extend the knowledge of the natural history of Fabry disease and to assess the effects of enzyme replacement therapy (ERT) with agalsidase alfa. As of March 2009, 64 boys and 34 girls with Fabry disease had enrolled in the FOS and been treated with agalsidase alfa for at least 6 months. The prevalence of symptoms tended to be reduced after 12 and 24 months of ERT in patients who experienced symptoms at baseline. In the entire population, non-significant decreases in the prevalence of gastrointestinal problems in boys and pain crises in girls were observed after 12-24 months. Kidney function and left ventricular mass indexed to height remaine…

Malemedicine.medical_specialtyPediatricsTime FactorsAdolescentRenal functionInternal medicineGeneticsmedicineHumansEnzyme Replacement TherapyChildAdverse effectGenetics (clinical)business.industryEnzyme replacement therapymedicine.diseaseFabry diseaseNatural historyTreatment OutcomeEndocrinologyEl NiñoChild Preschoolalpha-GalactosidaseFabry DiseaseFemaleObservational studybusinessAgalsidase alfaClinical Genetics
researchProduct

Association between general and oral health-related quality of life in patients treated for oral cancer

2015

Background Less is known about the association between general health-related quality of life (HRQoL) and oral HRQoL (OHRQoL) among patients with specific diseases. The aim of this study was to assess the association between patient-centered outcome measurements (HRQoL and OHRQoL) of oral cancer patients at least 6 months after treatment. Material and Methods HRQoL was measured with the 12-Item Short Form Health Survey (SF-12); OHRQoL was evaluated using the Oral Health Impact Profile (OHIP-14) and the Oral Impacts on Daily Performances (OIDP). Results Higher OHRQoL scores were associated with lower SF-12 domains scores. The OHIP-14 explained 16.5 % of the total variance of SF-12 Physical C…

Malemedicine.medical_specialtyPediatricsTime FactorsPsychological interventionOral HealthOdontologíaOral healthQuality of lifeSurveys and QuestionnairesInternal medicinemedicineHumansIn patientAssociation (psychology)General DentistryAgedMouth neoplasmOral Medicine and Pathologybusiness.industryResearchCancerMiddle Agedmedicine.disease:CIENCIAS MÉDICAS [UNESCO]Ciencias de la saludhumanitiesPatient Outcome Assessmentstomatognathic diseasesOtorhinolaryngologyUNESCO::CIENCIAS MÉDICASQuality of LifeFemaleMouth NeoplasmsSurgerybusinessAfter treatment
researchProduct